Pages that link to "Q44125775"

The following pages link to Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab (Q44125775):

Displaying 11 items.

• Primary central nervous system diffuse large B-cell lymphoma in the immunocompetent: Immunophenotypic subtypes and Epstein-Barr virus association (Q34574781) (← links)
• Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms (Q34617849) (← links)
• Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 cases (Q37353917) (← links)
• New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009. (Q37716643) (← links)
• Biological prognostic markers in diffuse large B-cell lymphoma (Q38019791) (← links)
• Accelerated therapeutic progress in diffuse large B cell lymphoma (Q38174498) (← links)
• Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era (Q42867439) (← links)
• Diffuse large B-cell lymphoma primary of lung. (Q43905145) (← links)
• Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection (Q45372503) (← links)
• Different predictive values of interim 18F-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma. (Q48355928) (← links)
• Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression. (Q54563401) (← links)